Nanobiotix S.A.

Healthcare

NASDAQ:NBTX · NASDAQ Global Select

Market Cap $1.84B Beta 0.59 P/E (TTM) -60.2

$36.27 -0.91%

-$0.33 today

52W Low $4.31High $57.14

Vol 0.05M · Avg 0.08M

EPS (TTM) -$0.51Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+720.59%

Period High

$55.07

Period Low

$4.41

Latest

$36.27

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Tyra Biosciences, Inc.

NASDAQ:TYRA

$1.69B

GH Research PLC

NASDAQ:GHRS

$1.50B

EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

$1.13B

Savara Inc.

NASDAQ:SVRA

$1.11B

ARS Pharmaceuticals, Inc.

NASDAQ:SPRY

$964.72M

Arbutus Biopharma Corporation

NASDAQ:ABUS

$883.98M

Kura Oncology, Inc.

NASDAQ:KURA

$850.01M

Rezolute, Inc.

NASDAQ:RZLT

$490.13M

ProKidney Corp.

NASDAQ:PROK

$263.00M

LENZ Therapeutics, Inc.

NASDAQ:LENZ

$190.79M

What is the latest NBTX filing?

The latest filing shown is S-8 dated Jun 8, 2026.

How many recent filings does NBTX have?

Intrinsic Alpha currently shows 20 recent filings for NBTX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.